Company filings profile · CIK 0001515673
Ultragenyx Pharmaceutical Inc. — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Ultragenyx Pharmaceutical Inc. (RARE): 27 filings in the last 90 days vs 40 in the prior 90 (filing-velocity cooling ↓ · 0.68×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Aug 5, 2026. Source-linked, daily-refreshed.
Material 8-K events — Ultragenyx Pharmaceutical Inc.
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Aug 4, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 18, 2026 | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| May 5, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
Watch Ultragenyx Pharmaceutical Inc. automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Aug 5, 2026 | 10-Q | 10-Q | ↗ |
| Aug 4, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Aug 4, 2026 | 4 | 4 | ↗ |
| Aug 4, 2026 | 4 | 4 | ↗ |
| Aug 3, 2026 | 144 | ↗ | |
| Jul 31, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 31, 2026 | SCHEDULE 13G | ↗ | |
| Jul 30, 2026 | SCHEDULE 13G/A | ↗ | |
| Jul 6, 2026 | 4 | 4 | ↗ |
| Jul 1, 2026 | 144 | ↗ | |
| Jun 15, 2026 | 4 | 4 | ↗ |
| Jun 15, 2026 | 4 | 4 | ↗ |
| Jun 15, 2026 | 144 | ↗ | |
| Jun 15, 2026 | 144 | ↗ | |
| Jun 12, 2026 | S-8 | S-8 | ↗ |
| Jun 1, 2026 | 4 | 4 | ↗ |
| Jun 1, 2026 | 144 | ↗ | |
| May 18, 2026 | 4 | 4 | ↗ |
| May 18, 2026 | 4 | 4 | ↗ |
| May 18, 2026 | 4 | 4 | ↗ |
| May 18, 2026 | 4 | 4 | ↗ |
| May 18, 2026 | 4 | 4 | ↗ |
| May 18, 2026 | 4 | 4 | ↗ |
| May 18, 2026 | 4 | 4 | ↗ |
| May 18, 2026 | 144 | ↗ | |
| May 18, 2026 | 8-K | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| May 12, 2026 | SCHEDULE 13G | ↗ | |
| May 6, 2026 | 4 | 4 | ↗ |
| May 6, 2026 | 10-Q | 10-Q | ↗ |
| May 5, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 4, 2026 | 4 | 4 | ↗ |
| May 1, 2026 | 144 | ↗ | |
| Apr 30, 2026 | DEFA14A | DEFA14A | ↗ |
| Apr 29, 2026 | SCHEDULE 13G | ↗ | |
| Apr 24, 2026 | 4 | 4 | ↗ |
| Apr 20, 2026 | 4 | 4 | ↗ |
| Apr 20, 2026 | 4 | 4 | ↗ |
| Apr 20, 2026 | 4 | 4 | ↗ |
| Apr 20, 2026 | 4 | 4 | ↗ |
| Apr 20, 2026 | 4 | 4 | ↗ |